Protalix BioTherapeutics, Inc. (PLX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$2.63
Day's range
$2.9

Protalix BioTherapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 3.65 M $6.56 M   2.71% 4.60%
OPALEYE MANAGEMENT INC. 04/13/2026 2.48 M $4.46 M   -3.97% 3.13%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 1.26 M $2.27 M   -3.96% 1.59%
NORTHERN TRUST CORP 02/17/2026 865.71 K $1.56 M   -4.07% 1.09%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 830.05 K $1.49 M   1.25% 1.05%
STATE STREET CORP 02/13/2026 585.26 K $1.05 M   17.39% 0.74%
STRATOS WEALTH PARTNERS, LTD. 01/20/2026 500.00 K $900.00 K   0.00% 0.63%
VANGUARD GROUP INC 01/29/2026 488.55 K $879.39 K   5.20% 0.62%
CITADEL ADVISORS LLC 02/17/2026 317.63 K $571.73 K   751.41% 0.40%
JANE STREET GROUP, LLC 02/12/2026 289.92 K $521.85 K   100.00% 0.37%
GOLDMAN SACHS GROUP INC 03/25/2026 262.81 K $473.06 K   74.24% 0.33%
UBS GROUP AG 01/29/2026 262.52 K $472.54 K   37.97% 0.33%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2026 232.09 K $417.77 K   -42.03% 0.29%
MAIN STREET FINANCIAL SOLUTIONS, LLC 02/17/2026 214.10 K $385.38 K   65.84% 0.27%
BANK OF NEW YORK MELLON CORP 02/10/2026 210.87 K $379.56 K   52.20% 0.27%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/17/2026 189.10 K $340.38 K   0.00% 0.24%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 175.07 K $315.13 K   0.00% 0.22%
COMMONWEALTH EQUITY SERVICES, LLC 02/12/2026 171.77 K $309.19 K   0.00% 0.22%
EVERGREEN CAPITAL MANAGEMENT LLC 01/27/2026 171.34 K $308.41 K   0.00% 0.22%
ROUND ROCK ADVISORS, LLC 04/07/2026 155.10 K $279.18 K   100.00% 0.20%
DIAMETRIC CAPITAL, LP 02/13/2026 138.93 K $250.07 K   -22.81% 0.18%
MORGAN STANLEY 02/13/2026 131.99 K $237.58 K   85.80% 0.17%
BARCLAYS PLC 02/13/2026 112.85 K $203.13 K   10.86% 0.14%
NUVEEN, LLC 02/12/2026 90.19 K $162.34 K   0.00% 0.11%
WELLS FARGO & COMPANY/MN 02/13/2026 79.00 K $142.20 K   84.45% 0.10%
LAZARD ASSET MANAGEMENT LLC 02/17/2026 71.39 K $128.51 K   100.00% 0.09%
HRT FINANCIAL LP 02/12/2026 64.61 K $116.00 K   100.00% 0.08%
ORIN GREEN FINANCIAL, LLC 02/06/2026 61.43 K $110.58 K   0.38% 0.08%
INVESCO LTD. 02/19/2026 50.56 K $91.01 K   12.35% 0.06%
BANK OF AMERICA CORP /DE/ 02/17/2026 46.35 K $83.43 K   130.39% 0.06%
RHUMBLINE ADVISERS 02/13/2026 44.37 K $79.86 K   -31.94% 0.06%
TWO SIGMA SECURITIES, LLC 02/17/2026 39.81 K $71.66 K   100.00% 0.05%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 38.52 K $69.33 K   -47.18% 0.05%
PRICE T ROWE ASSOCIATES INC /MD/ 02/17/2026 35.28 K $64.00 K   0.00% 0.04%
XTX TOPCO LTD 02/17/2026 34.30 K $61.73 K   -60.05% 0.04%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 02/17/2026 33.25 K $59.84 K   3.08% 0.04%
INTECH INVESTMENT MANAGEMENT LLC 02/10/2026 31.13 K $56.04 K   -0.37% 0.04%
NEW YORK STATE COMMON RETIREMENT FUND 02/12/2026 31.10 K $55.98 K   -24.70% 0.04%
JPMORGAN CHASE & CO 02/11/2026 30.87 K $55.57 K   2.94% 0.04%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 28.74 K $51.47 K   68.80% 0.04%
CITADEL ADVISORS LLC 02/17/2026 27.60 K $49.68 K   74.68% 0.03%
APTUS CAPITAL ADVISORS, LLC 02/13/2026 26.61 K $47.90 K   3.43% 0.03%
CAPITAL PERFORMANCE ADVISORS LLP 01/27/2026 25.98 K $46.76 K   0.00% 0.03%
SMARTLEAF ASSET MANAGEMENT LLC 02/13/2026 25.98 K $45.20 K   100.00% 0.03%
PRELUDE CAPITAL MANAGEMENT, LLC 02/17/2026 22.24 K $40.04 K   -55.33% 0.03%
STATE OF ALASKA, DEPARTMENT OF REVENUE 01/23/2026 21.83 K $39.00 K   100.00% 0.03%
MARSHALL WACE, LLP 02/13/2026 19.08 K $34.34 K   100.00% 0.02%
POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY 02/13/2026 18.55 K $33.40 K   0.00% 0.02%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 02/13/2026 18.50 K $33.30 K   -23.10% 0.02%
SG AMERICAS SECURITIES, LLC 01/09/2026 17.16 K $31.00 K   100.00% 0.02%

Protalix BioTherapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 98 institutional investors and hedge funds held shares of Protalix BioTherapeutics Inc.. The most heavily invested institutionals were:

Stratos Wealth Partners, LTD.: 500,000

Prospera Financial Services Inc: 418,570

UBS Group AG: 265,535

Bank of New York Mellon Corp: 219,307

Nuveen, LLC: 90,188

Orin Green Financial, LLC: 64,433

18.80% of Protalix BioTherapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 15.77 M shares in the last 24 months. This purchase volume represents approximately $45.42 M in transactions.